InvestorQ : Can you tell me more about the stellar performance of Natco Pharma based out of Hyderabad in Southern India? What have been the triggers for this growth?
Niti Shenoi made post

Can you tell me more about the stellar performance of Natco Pharma based out of Hyderabad in Southern India? What have been the triggers for this growth?

Answer
image
2 weeks ago
Follow

Natco Pharma reported 65.2% growth in sales in the Sep-20 quarter at Rs.802 crore. APIs and formulations have been extremely strong and the core oncology products of Natco as well as the APIs had a robust growth in demand from India and from abroad.

Natco reported 120.4% growth in operating profits at Rs248 crore largely due to lower cost of materials consumed and better working capital management. The PAT for the Sep-20 quarter was up also by 73% at Rs.204 crore, which could have bene higher but for tax spurt.

For Natco, 60% revenues came from formulation exports and 14% from domestic formulations sales while APIs contributed 25%. That is perhaps the big growth area.

0 Views